Rebopag 25 mg Tablet 7's is classified as a platelet-stimulating agent and is primarily used to address low blood platelet count in patients diagnosed with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Furthermore, Rebopag 25 mg Tablet 7's is also employed in the treatment of severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura refers to an autoimmune condition characterized by diminished platelet levels, while hepatitis C is a liver infection caused by the hepatitis C virus. On the other hand, severe aplastic anaemia is a medical condition wherein the bone marrow inadequately produces blood cells.

The active ingredient in Rebopag 25 mg Tablet 7's is 'Eltrombopag', falling under the category of thrombopoietin receptor agonists. Thrombopoietin is a glycoprotein hormone that plays a pivotal role in triggering the formation of megakaryocytes, which are significant bone marrow cells responsible for platelet production. By augmenting these specialized bone marrow cells, Rebopag 25 mg Tablet 7's enhances the platelet count, thereby reducing the likelihood of bleeding episodes.

It is imperative to adhere to the prescribed dosage of Rebopag 25 mg Tablet 7's as directed by your healthcare provider. In specific instances, common side effects such as nausea, diarrhoea, headache, muscle pain, fatigue, decreased appetite, fever, anaemia, cough, and tingling numbness may manifest. These adverse reactions vary among individuals and are not experienced by all who consume Rebopag 25 mg Tablet 7's. Should you encounter any side effects that prove difficult to manage, it is recommended to seek advice from your medical practitioner.

Before initiating Rebopag 25 mg Tablet 7's, it is crucial to communicate any allergic reactions you may have to this medication or other drugs to your healthcare provider. Additionally, disclosure of any preexisting heart, kidney, or liver conditions, blood disorders, coagulation abnormalities, or cataracts is essential before commencing treatment with Rebopag 25 mg Tablet 7's. Expectant mothers or individuals planning to conceive should consult their doctor before taking Rebopag 25 mg Tablet 7's, as its safety during pregnancy is subject to medical evaluation. Moreover, as Rebopag 25 mg Tablet 7's can induce dizziness, it is advisable to refrain from driving or operating machinery unless you are fully alert. This medication is contraindicated for use during breastfeeding as it can pass into breast milk, potentially affecting the infant.

Rebopag 25mg Tablet offers several benefits in treating specific medical conditions. Firstly, in cases of chronic idiopathic thrombocytopenic purpura (ITP) or Hepatitis C virus (HCV) infection, this medication helps increase the number of platelets in the blood. Low platelet count can lead to a higher risk of bleeding, and Rebopag 25mg Tablet works by stimulating the production of platelets to prevent such episodes. This benefit is significant for both adults and children aged 1 year and older suffering from ITP or HCV infection, who have not responded to other treatments.

Moreover, Rebopag 25mg Tablet is also effective in managing severe aplastic anemia, a condition where the body fails to generate an adequate amount of new blood cells. When used in combination with other medications, this tablet aids in boosting the production of platelets by increasing megakaryocytes, the bone marrow cells responsible for platelet production. By enhancing the number of platelets in the blood, Rebopag 25mg Tablet helps in reducing the risk of bleeding and supports overall health in adults and children aged 2 years and above with severe aplastic anemia.

Overall, the key benefit of Rebopag 25mg Tablet lies in its ability to address low platelet count in patients with immune thrombocytopenic purpura, HCV infections, and severe aplastic anemia by stimulating platelet production, thereby reducing the incidence of bleeding episodes and improving the quality of life for individuals affected by these conditions. It is important to follow the doctor's guidance on the dosage and usage of this medication to experience the maximum benefits it offers.

To properly use Rebopag 25mg Tablet, follow the instructions given to you by your doctor. Swallow the tablet whole with a glass of water on an empty stomach, as directed. Avoid crushing, chewing, or breaking the tablet. If you are prescribed the oral suspension, make sure to shake the bottle well before use. Measure the prescribed dose using the measuring cup, dosing syringe, or dropper provided in the packaging. For the powder form, mix the powder with the recommended amount of water and take it with or without food as per your doctor's instructions. Your physician will determine the appropriate dosage and duration based on factors such as your age, body weight, and medical condition. Always adhere to your doctor's guidance to ensure the safe and effective use of Rebopag 25mg Tablet.

Rebopag 25mg Tablet is primarily used to treat conditions caused by low platelet count, such as immune thrombocytopenia (ITP) and thrombocytopenia in adults with hepatitis C infection. It is also effective in managing low blood count in adults with severe aplastic anemia, a rare blood disorder stemming from bone marrow dysfunction hindering new blood cell production. This medication plays a pivotal role in overcoming these conditions by boosting platelet levels, thereby aiding in blood clotting and overall blood count management.

Rebopag 25mg Tablet is used to treat immune (idiopathic) thrombocytopenic purpura (ITP), a condition where there are low platelet levels in the blood, leading to abnormal clotting. It is caused by the immune system attacking its own platelets. ITP can also occur in children after a viral infection and symptoms may include easy bruising, bleeding from gums and nose, blood in urine and stools, heavy menstrual flow, and reddish-purple spots on the lower legs. Hepatitis C, an infection and liver inflammation, and severe aplastic anaemia (SAA), where the bone marrow doesn't produce enough blood cells, are other conditions that Revolade can help manage.

It is essential to consult your doctor before taking Rebopag 25mg Tablet if you have any of the following conditions:

1. At risk of developing blood clots in veins or arteries.
2. Suffering from cancer.
3. Recently undergone surgery or had a physical injury.
4. Obesity.
5. Smoking habits.
6. Cataracts (clouding of the eye lens).
7. Another blood condition like myelodysplastic syndrome.

If you experience any concerning symptoms or side effects while taking Rebopag 25mg Tablet, such as unexplained bruising, bleeding, or vision changes, it is important to seek medical attention promptly. Your doctor can provide guidance on the best course of action based on your individual health needs and ensure your safety and well-being.

Common side effects of Rebopag 25mg Tablet include nausea, diarrhea, upper respiratory tract infection, vomiting, increased liver enzymes, muscle pain, and urinary tract infection. Other possible side effects may involve headache, tiredness, loss of appetite, fever, anaemia, cough, and tingling or numbness sensations. In rare cases, severe side effects may occur, such as allergic reactions, interruption of blood supply to parts of the heart, blood clots in the lungs or veins, blockade in lung arteries, and liver damage or injury. Additional serious side effects may manifest as heart and blood vessel disorders, nerve damage, gastrointestinal issues like rectal bleeding, skin problems, eye complications, kidney problems, and changes in red blood cell shape. Stop taking Rebopag 25mg Tablet and seek immediate medical attention if you experience signs of blood clots, liver problems, or bleeding in the digestive system. It is essential to consult your healthcare provider if you have concerns about the side effects or their persistence.

Before taking Rebopag 25mg Tablet 7's, make sure to tell your doctor if you have any allergies to this medication or other drugs. Inform your healthcare provider about your medical history, especially if you have a history of blood clots, clotting disorders, blood disorders like blood cancer, myelodysplastic syndrome, cataracts, or liver and kidney diseases. It's important to take Rebopag 25mg Tablet 7's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements, dairy products, and calcium-enriched foods as they can interfere with its absorption.

Avoid using Rebopag 25mg Tablet 7's during pregnancy as it may harm the unborn baby. Consult your doctor before using this medication if you are breastfeeding. Refrain from driving or operating machinery while taking Rebopag 25mg Tablet 7's, as it may cause dizziness and tiredness, affecting your ability to concentrate. Limit alcohol intake while on Rebopag 25mg Tablet 7's, as it may impact the effectiveness of the medication. This medication is not recommended for children under one year old for ITP and under two years old for SAA.

If you forget to take a dose of Rebopag 25mg Tablet, just skip that missed dose and resume your regular dosing schedule. It is important not to take extra doses to make up for the missed one. If you have any concerns or questions about missed doses, feel free to consult your healthcare provider for further guidance.

In case of taking too much of Rebopag 25mg Tablet by accident, it's important to seek immediate medical help. Contact your doctor right away or go to the nearest hospital if you suspect an overdose. Overdose symptoms may occur if the medication is consumed in excessive amounts. It is crucial to get timely medical assistance in such situations to manage and address any potential overdose effects.

In order to monitor the effects of Rebopag 25mg Tablet on your body, the following related lab tests may be done:

1. Complete Blood Count (CBC): This test helps to determine the levels of various blood components such as red blood cells, white blood cells, and platelets. It can provide information on how Revolade is affecting your blood cells.

2. Iron Studies: This test measures the levels of iron in your blood and helps in diagnosing conditions related to iron deficiency or iron overload. It is important to monitor iron levels while taking Revolade.

3. Peripheral Smear Examination: This test involves looking at a sample of your blood under a microscope to examine the size, shape, and number of your blood cells. It can provide additional information on the effects of Revolade on your blood cells.

4. Vitamin B12: Testing your Vitamin B12 levels is important while taking Revolade, as this medication can affect the absorption of B12 in your body. Monitoring B12 levels can help prevent deficiencies that may arise due to the medication.

These lab tests will help your healthcare provider assess the effects of Rebopag 25mg Tablet on your body and ensure that you are receiving the best possible care during your treatment.